Ana M. Aparicio

The University of Texas MD Anderson Cancer Center

Also affiliated with University of San Andrés

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

2.5Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0479

Top 13%

1.6DataRank

Top 13%85 citations

Jun Yang, Peter D.A. Shepherd, Elsa M. Li-Ning-Tapia, Estefanía Labanca, Ganiraju C. Manyam +18 more

Papers

Driven by 27 papers — median percentile 71. Top paper: “Mesenchymal and stem-like prostate cancer linked to therapy-induced lineage plasticity and metastasis”.

Mesenchymal and stem-like prostate cancer linked to therapy-induced lineage plasticity and metastasis

Cell Reports(2022)10.1016/j.celrep.2022.110595

N/A

1.7DataRank · unranked

69 citations

Yan Wang, Josué Curto, Sreeharsha Gurrapu, Sara Laudato, Alekya Rumandla +20 more

The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0479

Top 13%

1.6DataRank

Top 13%85 citations

Jun Yang, Peter D.A. Shepherd, Elsa M. Li-Ning-Tapia, Estefanía Labanca, Ganiraju C. Manyam +18 more

Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironment

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002919

N/A

1.6DataRank · unranked

56 citations

Bilal A. Siddiqui, Ana M. Aparicio, Shalini S. Yadav, Sreyashi Basu, Hong Chen +8 more

Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) Series

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-2438

Top 29%

0.698DataRank

Top 29%27 citations

Estefanía Labanca, Peter D.A. Shepherd, Jiabin Dong, Jun Yang, Xiaofei Song +20 more

Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation

Cancer Discovery(2023)10.1158/2159-8290.cd-23-0754

N/A

0.626DataRank · unranked

64 citations

Orsetta Quaini, Kei Mizuno, Francesco Orlando, Yari Ciani, Sheng-Yu Ku +23 more

Archival single-cell genomics reveals persistent subclones during DCIS progression

Cell(2023)10.1016/j.cell.2023.07.024

N/A

0.612DataRank · unranked

58 citations

Tapsi Kumar, Junke Wang, Darlan Conterno Minussi, Emi Sei, Jianzhuo Li +27 more

Genotype-to-Phenotype Associations in the Aggressive Variant Prostate Cancer Molecular Profile (AVPC-m) Components

Cancers(2022)10.3390/cancers14133233

N/A

0.489DataRank · unranked

25 citations

Paul V. Viscuse, Patrick G. Pilié, Jingjing Liu, Souzana Logotheti, Caddie Laberiano-Fernández +18 more

Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1

JU Open Plus(2024)10.1097/ju9.0000000000000137

N/A

0.457DataRank · unranked

8 citations

Alan H. Bryce, Maha Hussain, Neeraj Agarwal, Himisha Beltran, Matthew R. Cooperberg +33 more

A candidate androgen signalling signature predictive of response to abiraterone acetate in men with metastatic castration-resistant prostate cancer

European Journal of Cancer(2020)10.1016/j.ejca.2019.12.027

N/A

0.435DataRank · unranked

7 citations

Nicholas Spetsieris, Justin A. Weldon, Alexandros Tsikkinis, Anh Hoang, Ana M. Aparicio +14 more

A Phase 2 Trial of Abiraterone Followed by Randomization to Addition of Dasatinib or Sunitinib in Men With Metastatic Castration-Resistant Prostate Cancer

Clinical Genitourinary Cancer(2020)10.1016/j.clgc.2020.05.013

N/A

0.425DataRank · unranked

16 citations

Myrto Boukovala, Justin A. Weldon, Alexandros Tsikkinis, Anh Hoang, Ana M. Aparicio +15 more

CHD1 Promotes Sensitivity to Aurora Kinase Inhibitors by Suppressing Interaction of AURKA with Its Coactivator TPX2

Cancer Research(2022)10.1158/0008-5472.can-22-0631

N/A

0.396DataRank · unranked

13 citations

Yin Wang, Kevin Lin, Varadha Balaji Venkadakrishnan, Martin Bakht, Wei Shi +16 more

A Modular Trial of Androgen Signaling Inhibitor Combinations Testing a Risk-Adapted Strategy in Patients with Metastatic Castration–Resistant Prostate Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3740

N/A

0.393DataRank · unranked

6 citations

Rebecca S. Tidwell, Shalini S. Yadav, Jiun‐Sheng Chen, Miao Zhang, Jingjing Liu +22 more

A deconvolution framework that uses single-cell sequencing plus a small benchmark data set for accurate analysis of cell type ratios in complex tissue samples

Genome Research(2024)10.1101/gr.278822.123

N/A

0.213DataRank · unranked

3 citations

Xiaoqian Liu, Xuesen Cheng, Yujie Jiang, Shuangxi Ji, Qingnan Liang +14 more

Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2

JU Open Plus(2024)10.1097/ju9.0000000000000138

N/A

0.208DataRank · unranked

3 citations

E. David Crawford, Neeraj Agarwal, Maha Hussain, Himisha Beltran, Matthew R. Cooperberg +33 more

Integrative analysis of the MD Anderson Prostate Cancer Patient-Derived Xenograft Series (MDA PCa PDX)

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.07.21.500652

Top 70%

0.165DataRank

Top 70%2 citations

Estefanía Labanca, Xiaofei Song, Jun Yang, Peter D.A. Shepherd, Jiabin Dong +18 more

Transcriptional Inactivation of TP53 and the BMP Pathway Mediates Therapy-induced Dedifferentiation and Metastasis in Prostate Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.04.14.439569

N/A

0.104DataRank · unranked

1 citations

Yan Wang, Josué Curto, Sreeharsha Gurrapu, Sara Laudato, Alekya Rumandla +19 more

Transcriptional Inactivation of TP53 and the BMP Pathway Mediates Therapy-induced Dedifferentiation and Metastasis in Prostate Cancer

Research Square(2021)10.21203/rs.3.rs-444925/v1

N/A

0DataRank · unranked

0 citations

Yan Wang, Josué Curto, Sreeharsha Gurrapu, Sara Laudato, Alekya Rumandla +19 more

Randomized Phase 2 Trial of Presurgical Androgen Deprivation Therapy With or Without Axitinib in Prostate Cancer Presenting With Lymph Node Metastasis

European Urology Oncology(2025)10.1016/j.euo.2025.04.015

N/A

0DataRank · unranked

0 citations

Rebecca S. Tidwell, Brian F. Chapin, Deborah Harris, Miao Zhang, Louis L. Pisters +11 more

Immune checkpoint B7-H3 is a therapeutic vulnerability in prostate cancer harboring PTEN and TP53 deficiencies

Science Translational Medicine(2023)10.1126/scitranslmed.adf6724

N/A

0DataRank · unranked

70 citations

Yin Wang, Yuehui Zhao, Justin J. Kim, Jiexi Li, Chenling Meng +9 more

Neoadjuvant apalutamide (APA) plus leuprolide (LHRHa) with or without abiraterone (AA) in localized high-risk prostate cancer (LHRPC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.5504

N/A

0DataRank · unranked

18 citations

Myrto Boukovala, Nicholas Spetsieris, Sijin Wen, Anh Hoang, Justin A. Weldon +15 more

Cardiometabolic healthcare for men with prostate cancer: an MD Anderson Cancer Center experience

Cardio-Oncology(2023)10.1186/s40959-023-00186-x

N/A

0DataRank · unranked

12 citations

Whittney S. Thoman, Efstratios Koutroumpakis, Amer Abdulla, Sumit K. Subudhi, Ana M. Aparicio +4 more

HERCULES: A prostate cancer (PC) sequencing panel for parallel analysis of circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5036

N/A

0DataRank · unranked

0 citations

Jonathan D. Buckley, Dejerianne Ostrow, Jean‐Hugues Parmentier, Smruthi Maganti, Scott A. Mitchell +14 more

DeMixSC: a deconvolution framework that uses single-cell sequencing plus a small benchmark dataset for improved analysis of cell-type ratios in complex tissue samples

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.10.10.561733

N/A

0DataRank · unranked

0 citations

Xiaoqian Liu, Xuesen Cheng, Yujie Jiang, Shuangxi Ji, Qingnan Liang +12 more

Continuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND Trial

European Urology(2025)10.1016/j.eururo.2025.07.006

N/A

0DataRank · unranked

24 citations

Bilal A. Siddiqui, Cara Haymaker, Bryan Fellman, Marina Nayeli Medina-Rosales, Tharakeswara Bathala +26 more

CHD1 loss reprograms SREBP2-driven cholesterol synthesis to fuel androgen-responsive growth and castration resistance in SPOP-mutated prostate tumors

Nature Cancer(2025)10.1038/s43018-025-00952-z

N/A

0DataRank · unranked

11 citations

Jiexi Li, Yin Wang, Ximing Tang, Kevin Lin, Qidong Li +16 more

Integrating systemic therapy and metastasis-directed therapy in oligometastatic hormone-sensitive prostate cancer

Prostate Cancer and Prostatic Diseases(2025)10.1038/s41391-025-01041-z

N/A

0DataRank · unranked

2 citations

Jarey H. Wang, Brian F. Chapin, Ana M. Aparicio, Sumit K. Subudhi, Phuoc T. Tran +9 more

Combined genomic profiling of cell-free DNA (cfDNA) and circulating tumor cell DNA (ctcDNA) in S1802, a prospective phase 3 trial for metastatic prostate cancer (mHSPC).

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.e17111

N/A

0DataRank · unranked

1 citations

Jonathan D. Buckley, Scott A. Mitchell, Dejerianne Ostrow, Jean‐Hugues Parmentier, Samin Maleki Jahan +13 more

Ana M. Aparicio

Indexed papers

Top data-sharing exemplar

Papers